Evidence map›Paper›PMID 38116539›Full record

ArticleFrontiers in cardiovascular medicine2023

Advancing paediatric cardiac imaging: a comprehensive analysis of the feasibility and accuracy of a novel 3D paediatric transoesophageal probe.

Clément Karsenty, Khaled Hadeed, Pierrick Pyra, Aitor Guitarte, Camelia Djeddai, Remi Vincent, Yves Dulac, Ia Silagdze, Julie Gobin, Nicolas Combes and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Clément KarsentyDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Khaled HadeedDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Pierrick PyraDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Aitor GuitarteDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Camelia DjeddaiDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Remi VincentDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Yves DulacDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Ia SilagdzeDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Julie GobinDepartment of Anesthesiology and Paediatric Cardiology, University Hospital, Toulouse, France.
Nicolas CombesDepartment of Cardiology, Clinique Pasteur [Pasteur Clinic], Toulouse, France.
Miarisoa RatsimandresyDepartment of Cardiology, Clinique Pasteur [Pasteur Clinic], Toulouse, France.
Lionel BerthomieuDepartment of Intensive Care Unit and Paediatric Cardiology, University Hospital, Toulouse, France.
Davide CalvarusoDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Philippe AcarDepartment of Paediatric Cardiology, University Hospital, Toulouse, France.
Université Fédérale de Toulouse Midi-Pyrénées · FRClinique Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Pediatric transoesophageal echocardiography (TOE) probes have remained two-dimensional (2D) limiting their use compared to adults. While critical in pediatrics for interventions and post-surgery assessments, technological advancements introduced a three-dimensional (3D) pediatric TOE probe. This study assessed the new 3D pediatric TOE probe (GE 9VT-D) for feasibility, handling, and imaging quality. Methods and results: At Children's Hospital of Toulouse, 2-month prospective study enrolled children undergoing TOE with the new probe. All imaging modalities were rated by 2 operators using a 5-point Likert-type scale from 1 (very poor) to 5 (very good) quality. Forty-five children, median age 3.7 (range: 2 months-14.7 years) median weight 7.8 kg (range: 4.3-48 kg) underwent 60 TOEs: 25% pre-surgery, 45% post-surgery, 28% during percutaneous procedures, and 2% in intensive care. Probe handling was "very easy" in all cases without adverse events. The median score of 2D, 2D colour, pulsed Doppler and 3D were noted 5 out of 5 and continuous Doppler and 3D colour 4 out of 5. The 3D image quality remained consistent irrespective of the patient weighing above or below 7.8 kg ( Conclusion: Our comprehensive evaluation demonstrates that the new 3D pediatric TOE probe is feasible and provides high-quality imaging in pediatric patients. The successful integration of this novel probe into clinical practice has the potential to enhance diagnostic accuracy and procedural planning, ultimately optimizing patient outcomes in pediatric cardiac care.

Indexed as

3D echocardiographycardiac cateterismcomplex congenital heart diseasecongenital heart diseasepediatricpediatric cardiac surgerytransoesophageal echocardiography

Identifiers

PMID38116539
PMCPMC10728472
OpenAlexW4389345540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.